Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. scores highest on Nitro (91) and lowest on Price (14). Its PosiPenta is 61.30 out of 100, better than most similar companies.
On the Penta Grid this week, Amneal Pharmaceuticals, Inc. is Grid #125 of 837 in the Healthcare sector in United States, and Grid #489 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. | 61.30 | 14 | 83 | 91 | 50 | 68 |
| Praxis Precision Medicines, Inc. | 40.95 | 13 | 24 | 62 | 69 | 36 |
| Ionis Pharmaceuticals, Inc. | 31.29 | 4 | 43 | 34 | 16 | 59 |
| Chemed Corporation | 66.89 | 33 | 73 | 91 | 64 | 73 |
| Hims & Hers Health, Inc. | 41.96 | 3 | 75 | 53 | 32 | 47 |
| PACS Group, Inc. | 62.10 | 33 | 74 | 96 | 50 | 58 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 39.14 |
| P/B ratio | 202.29 |
EEarnings
| Trailing EPS | ₹46.41 |
| Forward EPS | ₹112.95 |
NNitro
| Price | 1816.63 |
| 52-week high | 2005.59 |
| 52-week low | 924.89 |
| Fall from 52-week high | 9.4% |
TTorque
| Return on equity (ROE) | 613.02% |
| Debt-to-equity | 23.87 |
AAnchor
| Beta (price swings) | 1.22 |
| Market cap | ₹63,272 Cr |
| Insider holding | 52.10% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Amneal Pharmaceuticals, Inc.'s PosiPenta score?
Amneal Pharmaceuticals, Inc.'s PosiPenta is 61.30 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Amneal Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Amneal Pharmaceuticals, Inc. is Grid #125 of 837 in the Healthcare sector in United States, and Grid #489 of 4,000 in United States.
Which PosiPenta pillar is strongest for Amneal Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 91 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Amneal Pharmaceuticals, Inc.?
Price (valuation), with a score of 14 out of 100: much weaker than most similar companies.
Has Amneal Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 11.93 points, from 49.37 to 61.30.
PositoAI is for research and education only and is not investment advice.